Employees at private schools in Sharjah who have not been vaccinated must undergo PCR testing every two weeks, education officials said.
The decision is part of efforts to curb the spread of Covid-19.
Staff at private education institutions who have taken both doses of a vaccine are exempt from the rule.
Sharjah Education Authority said unvaccinated workers must pay for the tests themselves.
Employers, however, will cover the costs for employees who provide a medical report that exempts them from taking the vaccine due to a health condition or illness, the authority said.
"Based on the developments related to Covid-19, and with the aim to ensure the safety of all workers and students in private educational institutions in the emirate, all workers in educational institutions must conduct the nasal swab (PCR examination) for workers in educational institutions every 14 days at their own expense, with the exception of workers who have obtained the Covid-19 vaccine [two doses]," the authority said in the circular.
Educational establishments must provide the authority with information about the number of employees who have taken the vaccine.
Teams will also be sent out to verify the negative PCR tests submitted by staffers and the vaccination certificates.
The UAE this week approved the use of the coronavirus vaccine for teenagers aged 16 and above.
Two vaccinations are available in the UAE.
The Sinopharm vaccine has been approved for nationwide use, including in Sharjah.
The Pfizer-BioNTech vaccine is being administered in Dubai.
Free vaccination campaigns are underway for both vaccines.
The number of vaccine doses administered across the country is approaching two million.
UAE’s leaders have encouraged people to be immunised as soon as possible to control the outbreak and help rebuild the economy.
Sheikh Mohammed bin Rashid, Vice President and Ruler of Dubai, is among the UAE leaders who have received the Sinopharm vaccine.
Benefits of first-time home buyers' scheme
- Priority access to new homes from participating developers
- Discounts on sales price of off-plan units
- Flexible payment plans from developers
- Mortgages with better interest rates, faster approval times and reduced fees
- DLD registration fee can be paid through banks or credit cards at zero interest rates
What is a Ponzi scheme?
A fraudulent investment operation where the scammer provides fake reports and generates returns for old investors through money paid by new investors, rather than through ligitimate business activities.
Trump v Khan
2016: Feud begins after Khan criticised Trump’s proposed Muslim travel ban to US
2017: Trump criticises Khan’s ‘no reason to be alarmed’ response to London Bridge terror attacks
2019: Trump calls Khan a “stone cold loser” before first state visit
2019: Trump tweets about “Khan’s Londonistan”, calling him “a national disgrace”
2022: Khan’s office attributes rise in Islamophobic abuse against the major to hostility stoked during Trump’s presidency
July 2025 During a golfing trip to Scotland, Trump calls Khan “a nasty person”
Sept 2025 Trump blames Khan for London’s “stabbings and the dirt and the filth”.
Dec 2025 Trump suggests migrants got Khan elected, calls him a “horrible, vicious, disgusting mayor”
The specs
Engine: 3.8-litre twin-turbo flat-six
Power: 650hp at 6,750rpm
Torque: 800Nm from 2,500-4,000rpm
Transmission: 8-speed dual-clutch auto
Fuel consumption: 11.12L/100km
Price: From Dh796,600
On sale: now
The Vile
Starring: Bdoor Mohammad, Jasem Alkharraz, Iman Tarik, Sarah Taibah
Director: Majid Al Ansari
Rating: 4/5
You Were Never Really Here
Director: Lynne Ramsay
Starring: Joaquim Phoenix, Ekaterina Samsonov
Four stars
PROFILE OF CURE.FIT
Started: July 2016
Founders: Mukesh Bansal and Ankit Nagori
Based: Bangalore, India
Sector: Health & wellness
Size: 500 employees
Investment: $250 million
Investors: Accel, Oaktree Capital (US); Chiratae Ventures, Epiq Capital, Innoven Capital, Kalaari Capital, Kotak Mahindra Bank, Piramal Group’s Anand Piramal, Pratithi Investment Trust, Ratan Tata (India); and Unilever Ventures (Unilever’s global venture capital arm)